Directors
Directors
2 directors, 1 in day-to-day management, no change since 2025
Act of 23-12-2025Permanent representative: TASSENOY HenriShareholding · Capital contribution
Board 2
CLINIMETRICS
Current
Director · since 01-04-2025 · term without a fixed end · Legal entity · permanent representative: Marc BUYSE · listed in the 2025 annual accounts, filed on 31-08-2026
NITYA
Current
Director and day-to-day manager · since 01-04-2025 · term without a fixed end · Legal entity · permanent representative: Céline BUYSE · listed in the 2025 annual accounts, filed on 31-08-2026
Day-to-day management 1
NITYA
Current
Director and day-to-day manager · appointed in the act of 23-07-2025 · term without a fixed end · Legal entity · permanent representative: Céline BUYSE
Permanent representatives 2
Céline BUYSE
Current
Permanent representative · appointed in the act of 23-07-2025 · for NITYA
Marc BUYSE
Current
Permanent representative · appointed in the act of 23-07-2025 · for CLINIMETRICS
Owners and capital
Shareholders
Contribution
act of 23-12-2025 ↗
- NITYA €2,500,000 in cash
Stated in the act
act of 23-12-2025 ↗
- NITYA all shares
Mandate history
4 people, 2 in office
- Board
- Day-to-day management
| Name | Functions and periods |
|---|---|
| CLINIMETRICS |
|
| NITYA |
|
| Céline BUYSE |
|
| Marc BUYSE |
|
Articles of association
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Frais de procédure et d’expertise pour moitié à charge du cédant et pour moitié à charge du ou des acquéreurs proportionnellement au nombre…”
Articles of association, deed of 31-01-2022 (in French)